The Affordable Care Act had a profound impact on the uninsured rate of U.S. adults with diabetes, according to a recent study from University of Southern California published in the journal of the American Diabetes Association, Diabetes Care.

As Purdue Pharma files for bankruptcy and prepares to settle a slew of lawsuits for approximately $10 billion for its role in the national opioid crisis, other drugmakers are hoping to latch onto the deal to resolve their own litigation threats.

If the researchers behind a new report on AI in healthcare are right, the technology could cut nonclinical workers’ workload by 40% while also slashing clinical tasks by 33%.

Thirty-five defendants have been charged by the Department of Justice in a Medicare fraud case worth more than $2.1 billion. The healthcare fraud case is one of the biggest ever charged.

Trumpcare healthcare plans pop up in online search results for health insurance, but there’s one problem: Trumpcare plans aren’t actually real.

CVS Pharmacy has pulled Zantac and other ranitidine products to treat heartburn, including CVS’ own brand, from its shelves following recalls and risks that the products contain probable human carcinogens.

As House Democrats launch a formal impeachment inquiry against President Trump, bipartisan healthcare efforts focused on lowering drug prices and healthcare costs are at risk of falling by the wayside, The Hill reported.

More major companies continue to jump on the problem of healthcare affordability, with the latest pilot launched by Sam’s Club, a membership-only warehouse retailer owned by Walmart.